118 related articles for article (PubMed ID: 1560432)
1. Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.
Ellinboe JW; Alessi TR; Dolak TM; Nguyen TT; Tomer JD; Guzzo F; Bagli JF; McCaleb ML
J Med Chem; 1992 Apr; 35(7):1176-83. PubMed ID: 1560432
[TBL] [Abstract][Full Text] [Related]
2. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
Wrobel J; Dietrich A; Woolson SA; Millen J; McCaleb M; Harrison MC; Hohman TC; Sredy J; Sullivan D
J Med Chem; 1992 Nov; 35(24):4613-27. PubMed ID: 1469692
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.
Zask A; Jirkovsky I; Nowicki JW; McCaleb ML
J Med Chem; 1990 May; 33(5):1418-23. PubMed ID: 2329563
[TBL] [Abstract][Full Text] [Related]
4. Antihyperglycemic activity of novel naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides.
Ellingboe JW; Lombardo LJ; Alessi TR; Nguyen TT; Guzzo F; Guinosso CJ; Bullington J; Browne EN; Bagli JF; Wrenn J
J Med Chem; 1993 Aug; 36(17):2485-93. PubMed ID: 8355249
[TBL] [Abstract][Full Text] [Related]
5. Perfluorocarbon-based antidiabetic agents.
Kees KL; Smith TM; McCaleb ML; Prozialeck DH; Cheeseman RS; Christos TE; Patt WC; Steiner KE
J Med Chem; 1992 Mar; 35(5):944-53. PubMed ID: 1548684
[TBL] [Abstract][Full Text] [Related]
6. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
[TBL] [Abstract][Full Text] [Related]
7. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
[TBL] [Abstract][Full Text] [Related]
8. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
9. Novel euglycemic and hypolipidemic agents. 1.
Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
[TBL] [Abstract][Full Text] [Related]
10. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
[TBL] [Abstract][Full Text] [Related]
11. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
[TBL] [Abstract][Full Text] [Related]
12. Novel thiazolidine-2,4-diones as potent euglycemic agents.
Hulin B; Clark DA; Goldstein SW; McDermott RE; Dambek PJ; Kappeler WH; Lamphere CH; Lewis DM; Rizzi JP
J Med Chem; 1992 May; 35(10):1853-64. PubMed ID: 1588563
[TBL] [Abstract][Full Text] [Related]
13. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
[TBL] [Abstract][Full Text] [Related]
14. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.
Malamas MS; Sredy J; McCaleb M; Gunawan I; Mihan B; Sullivan D
Eur J Med Chem; 2001 Jan; 36(1):31-42. PubMed ID: 11231047
[TBL] [Abstract][Full Text] [Related]
15. Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones.
Oguchi M; Wada K; Honma H; Tanaka A; Kaneko T; Sakakibara S; Ohsumi J; Serizawa N; Fujiwara T; Horikoshi H; Fujita T
J Med Chem; 2000 Aug; 43(16):3052-66. PubMed ID: 10956213
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
Kumar A; Sharma S; Gupta LP; Ahmad P; Srivastava SP; Rahuja N; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2012 Mar; 20(6):2172-9. PubMed ID: 22341243
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.
Imran M; Yar MS; Khan SA
Acta Pol Pharm; 2009; 66(1):51-6. PubMed ID: 19226969
[TBL] [Abstract][Full Text] [Related]
19. (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents.
Nomura M; Kinoshita S; Satoh H; Maeda T; Murakami K; Tsunoda M; Miyachi H; Awano K
Bioorg Med Chem Lett; 1999 Feb; 9(4):533-8. PubMed ID: 10098657
[TBL] [Abstract][Full Text] [Related]
20. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.
Cantello BC; Cawthorne MA; Cottam GP; Duff PT; Haigh D; Hindley RM; Lister CA; Smith SA; Thurlby PL
J Med Chem; 1994 Nov; 37(23):3977-85. PubMed ID: 7966158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
